Header placeholder lorem ipsum dolor sit amet, consectetur adipiscing elit.
Clinomics financials data including stock price, CreditSafe score, income statement, balance sheet, and cash flow.
Stock Price
₩593
2024-10-29
Market Capitalization
₩22.8 B
2024-10-29
Revenue
₩8.5 B
FY, 2024
CreditSafe Score
?
Score changed on Jun 14, 2026
Premium Content only available in Craft’s Intelligence Portal
View 30+ financial ratio metrics including price-to-earnings ratio, debt-to-assets ratio, gross profit margin, and more.
Financial ratio metrics help evaluate the financial strength of a company, and help raise red flags that can indicate potential risk, fulfillment challenges, or even possible bankruptcy.
Learn moreFinancial Statements
| KRW | FY, 2020 | FY, 2021 | FY, 2022 | FY, 2023 | FY, 2024 |
|---|---|---|---|---|---|
| Revenue | 9.8B | 55.4B | 23.1B | 11.4B | 8.5B |
| Cost of goods sold | 7.6B | 14.4B | 10.8B | 8.0B | 7.7B |
| Gross profit | 2.3B | 41.0B | 12.5B | 4.1B | 2.0B |
| Gross profit margin, % | 23.8% | 74.0% | 54.2% | 36.2% | 23.9% |
| Operating expense total | 12.6B | 15.4B | 19.1B | 33.7B | 26.0B |
| Depreciation and amortization | 1.9B | 2.6B | 4.0B | 4.4B | 10.4B |
| EBITDA | (10.3B) | 25.2B | (7.7B) | (31.3B) | (27.3B) |
| EBITDA margin, % | -104.6% | 45.4% | -33.3% | -274.8% | -320.6% |
| EBIT | (12.1B) | 22.5B | (11.8B) | (36.9B) | (39.5B) |
| EBIT margin, % | -123.7% | 40.6% | -51.1% | -323.6% | -464.1% |
| Interest income | 190.4M | 411.2M | 579.8M | 591.0M | 279.1M |
| Interest expense | 1.2B | 1.2B | 3.0B | 3.9B | 3.9B |
| Pre tax profit | (13.1B) | 24.8B | (10.1B) | (42.4B) | (47.1B) |
| Income tax expense | 944.0K | 9.0B | 112.5M | (32.1M) | (33.6M) |
| Net Income | (13.1B) | 15.9B | (10.2B) | (42.4B) | (47.1B) |